Related Experiment Video
Updated: Jun 4, 2026

09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
Changed histone acetylation patterns in normal-appearing white matter and early multiple sclerosis lesions
Xiomara Pedre1, Fabrizio Mastronardi, Wolfgang Bruck
1Department of Neuroscience, Mount Sinai School of Medicine, New York, New York 10029, USA.
Summary
Histone acetylation increases in aged and multiple sclerosis (MS) brains, inhibiting oligodendrocyte differentiation. Histone deacetylation occurs early in MS, decreasing with disease duration.
Area of Science:
- Neuroscience
- Epigenetics
- Cell Biology
Background:
- Oligodendrocyte differentiation is regulated by histone modifications, specifically acetylation and deacetylation.
- Histone acetylation, mediated by histone acetyltransferases (HATs) and histone deacetylases, influences gene transcription.
- Previous studies in rodents indicated histone deacetylation promotes oligodendrocyte differentiation, while acetylation inhibits it.
Purpose of the Study:
- To investigate the role of histone modifications in human brain aging and multiple sclerosis (MS).
- To examine changes in histone H3 acetylation and deacetylation in MS lesions.
- To correlate these epigenetic changes with oligodendrocyte differentiation inhibitors and disease progression.
Main Methods:
- Analysis of histone H3 acetylation and deacetylation in human brain samples from aged subjects and MS patients.
- Immunohistochemistry to detect acetylated histone H3 in NogoA+ oligodendrocytes.
- Quantitative PCR to measure transcript levels of HATs and oligodendrocyte differentiation inhibitors.
- Chromatin immunoprecipitation to assess histone H3 acetylation at target gene promoters.
Main Results:
- Increased histone H3 acetylation was observed in the white matter of aged human brains and in chronic MS lesions.
- Elevated levels of acetylated histone H3 were found in oligodendrocytes within a subset of MS samples.
- These acetylation changes correlated with increased expression of oligodendrocyte differentiation inhibitors (TCF7L2, ID2, SOX2) and higher HAT transcript levels (CBP, P300), particularly in female MS patients.
- Chromatin immunoprecipitation confirmed enrichment of acetyl-histone H3 at the promoter of TCF7L2 in MS patient samples.
- In contrast, early MS lesions showed significant oligodendroglial histone deacetylation.
Conclusions:
- Histone acetylation is associated with aging and chronic multiple sclerosis in the human brain.
- The shift towards histone acetylation in chronic MS correlates with increased transcriptional inhibitors, potentially hindering oligodendrocyte differentiation.
- Histone deacetylation appears to be an early event in MS, with its efficacy diminishing as the disease progresses.
Related Concept Videos
Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Histone Modification
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Spreading of Chromatin Modifications
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer is an enzyme that can...
Writers
The writer is an enzyme that can...

